During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky. The treatment landscape for breast cancer is shifting rapidly, driven by the rise of antibody-drug conjugates ...

Thirty-six progressive mCRPC patients received TLX591-Tx across three cohorts (enzalutamide, abiraterone, or docetaxel sequence), and all completed two planned doses without emergent, unexpected ...

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...

Leading expatriate blood cancer doctors and researchers have delivered a striking Open Letter to the Prime Minister pointing out the stark reality that underfunding Pharmac is leading to worse ...

Jeffrey Michael Kelly had over 120 firearms and 250,000 rounds of ammo seized after being accused of shooting a Democratic Party office in Tempe.

Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...

Exhaustion creeps in. Appetite vanishes. Hair thins. The person in the mirror looks gaunt. It's the paradox of cancer treatment: The same drugs meant to save a life can also wear the body down. Nick ...

Cancer drug pulled market as Ipsen removes Tazverik from the U.S. due to secondary blood cancer risks reported in clinical trials.

More than 60 years ago, the CIA kept private a report about notable cancer research, according to a 2011 declassified document.

A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment in colorectal cancer (CRC). The research, conducted by an international ...

The metabolism–cancer axis is currently at a critical inflection point. A landmark August 2025 JAMA Oncology study reported a 17% reduction in overall ...